The American Lung Association says that about 11 million people in the United States are suffering from the chronic obstructive pulmonary disease (COPD). However, it is unfortunate that about 24 million people have the disease but are not aware. COPD is a progressive lung disease that gives patients hard time breathing. There are two types of COPD, which are chronic bronchitis and emphysema. Most people suffering from COPD have a combination of both types. COPD causes the following changes in airways and lungs:
The above changes cause a reduction of the amount of air flowing in and out of the lungs. It deprives the body the much oxygen required, which makes it harder for patients to breathe. COPD has no cure. However, research shows that stem cells therapy is being used to treat patients with this lung disease.
COPD and stem cell treatment
Stem cells are present in the adult lung. Stem cells in the lungs were discovered just recently; therefore, there is no stem cell treatment for COPD patients, http://www.hawaiinewsnow.com/story/33635903/copd-patients-are-saying-yes-to-stem-cells-at-the-lung-institute-in-tampa. However, researchers say that stem cell therapy is a promising option for COPD treatment research. Researchers have a vision of using stem cells to generate new and healthy lungs in patients with chronic lung disease. Some of the ways stem cells will benefit COPD patients include:
About Lung Institute
The Lung Institute is a leading, innovative leader in regenerative medicine focusing on offering stem cell therapies for lung disease. The Institute is committed to offering patients an effective way of dealing with pulmonary conditions to improve their lives. The Lung Institute has treated more than 2000 patients, with 82% reporting an improvement in their lives, http://www.prweb.com/releases/2016/11/prweb13867190.htm .
The Lung Institute screens patients thoroughly to ensure best treatment results. They recognize that all patients require the best treatment. It has clinics in Dallas, Nashville, Texas, and Scottsdale.